Biofidelity has received £500,000 in grant funding from Innovate UK to co-fund a 12-month project validating its platform for the sensitive detection of mutations used to treat non-small-cell lung cancer.
OTIF portfolio company OrganOx has been awarded the 2019 Medtech Insight Award for ‘Best Proof-of-Value of an Innovation’.
In September 2019, Prof Lionel Tarassenko CBE was presented with an ‘Outstanding Achievement Award’ by Oxford Trust CEO, Steve Burgess, for his contribution to biomedical engineering and translational innovation in healthcare and technology systems, including work with Oxehealth.
Lightcast Discovery, was spun out of OTIF portfolio company Base4 Innovation in early 2019 to develop a next-generation microfluidic platform to revolutionise complex cell analysis. Today it announced the close of a £1.3m Seed round with investment from OTIF and other private investors to develop the capabilities and applications of its platform including continuing to expand its range of pilot studies.
OTIF portfolio company Keit Spectrometers has announced it has further established sales and support of the IRmadillo into Nordic countries